Proteome Sciences (LON:PRM) Stock Price Down 9.8% – What’s Next?

Proteome Sciences plc (LON:PRM)’s share price fell 9.8% during mid-day trading on Wednesday . The stock traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares traded hands during mid-day trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).

Proteome Sciences Trading Down 9.8 %

The firm’s fifty day moving average price is GBX 2.90 and its 200-day moving average price is GBX 3.12. The firm has a market cap of £9.37 million, a price-to-earnings ratio of -317.50 and a beta of 0.07.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.